Brian Maucere

especially for somebody who's a CEO is that he doesn't feel the need to say something immediately.

He thinks on it, looks off to the side.

It's not really concerned with whether the interviewer from Cisco is having to wait for that or the audience.

And then he starts speaking about it.

And I just, I like that about him.

That's not really one of the things I was going to bring up, but I do like that.

And then, um, scientific partnerships.

That's the next thing I wanted to bring up here because this one kind of hit the news, right?

Where they're like, Oh, open AI wants a piece of piece of your, you know, your search and stuff.

They want to, they want to be partners.

And he said, no, what he was saying was that for the next great scientific discovery, um,

let's say to cure a form of cancer, all cancer, we'll say a form of cancer, maybe breast cancer, something really, really big, that the costs for inference and compute are probably going to be astronomical.

in that he sees a potential, not something they're doing now, he's clear about that, but a potential future where they are almost like an investor, where they're fronting the cost of that inference and compute for maybe some research lab somewhere who says, hey, we think we have a really good shot at this, but...

We do not have the funding to do the level of inference and cost and compute that of a cost.

And then OpenAI comes in and says, we can help you there, but we also want a cut of the solution.

And so he was saying he sees them as being like an investor.

truthfully, I see no issue with this person.

I don't know what you guys feel about that because that's not the same thing as what came out, what I saw come out in the news, which is like, if you do something on Chachapiti, Chachapiti might want to cover that down the road because you use Chachapiti.

And he's talking about something at a much, much higher volume level

of scientific discovery, whatever that might be.